Name | 5-methyl-6-pyridin-4-yl-1,3-dihydroimidazo[4,5-b]pyridin-2-one |
---|---|
Synonyms |
2H-Imidazo(4,5-b)pyridin-2-one,1,3-dihydro-5-methyl-6-(4-pyridinyl)
5-Methyl-6-(4-pyridinyl)-2H-imidazo(4,5-b)pyridin-2-one Win-62005 |
Description | Win-62005 is a cyclic AMP phosphodiesterase III (PDE III) inhibitor with Kis of 25 and 26 nM for rat heart and canine aorta, respectively. |
---|---|
Related Catalog | |
Target |
Ki: 25 nM (PDE III), 25 nM (PDE III)[1] |
In Vitro | Win-62005 competitively inhibits cyclic GMP-inhibitable low Km cyclic AMP phosphodiesterase (PDE III) from rat heart and canine aorta with Ki values of 25±3 and 26±5 nM, respectively and is selective (at least 160-fold) for PDE III inhibition relative to other PDE isozymes[1]. |
In Vivo | After p.o. administration of 1 mg/kg Win-62005, LVdP/dtmax is significantly increased in 30 min and remains increased for at least 6 h[1]. |
References |
Density | 1.292g/cm3 |
---|---|
Boiling Point | 291.8ºC at 760 mmHg |
Molecular Formula | C12H10N4O |
Molecular Weight | 226.23400 |
Flash Point | 130.3ºC |
Exact Mass | 226.08500 |
PSA | 74.69000 |
LogP | 2.03390 |
Vapour Pressure | 0.00191mmHg at 25°C |
Index of Refraction | 1.621 |
Storage condition | 2-8℃ |